Smart intubation device developer Art Medical has raised $20 million in a new round of funding to support its platform of sensor-based smart tube solutions.
Funding in the current round was led by Advanced Medical Technologies, the Israel and Palo Alto, Calif.-based company said, and comes as the company is transitioning out of stealth mode.
Art Medical was founded in 2009 and raised $7 million from a combination of funding from the Israel Innovation Authority and Bill Gates’ Grand Challenge. The company is developing disposable sensor-enabled tubes that will offer continuous monitoring of gastric reflux, saliva and urine output.
The system consists of the sensor-equipped tubes and a console-based dashboard, and is designed to help alert attending nurses and physicians of any abnormalities in hopes of preventing patient complications.
The smart intubation platform has already received CE Mark approval and FDA clearance, according to MobiHealth News, with clinical studies underway in the US.
“One of the challenges for the ICU staff is patients’ prolonged length of stay and mortality from complications which are unrelated to the original reason of hospitalization. Aspiration of foreign materials is a major risk for intubated patients and technology is what is needed to solve this problem. We are confident that Art Medical has the solution,” founder and CEO Liron Elia said in a press release.
